This activity is designed for Physicians, Advanced Practice Providers, and other Allied Professionals in the Field of EP.
Nicoline van den Berg, MD, PhD | Amsterdam UMC
Honoraria/Speaking/Consulting: Julius Research, BV
Mihail Chelu, MD, PhD, FHRS | Baylor College of Medicine
Research (Contracted Grants for PIs and Named Investigators Only): Abbott, Impulse Dynamics
Honoraria/Speaking/Consulting: Impulse Dynamics
Juan Diaz, MD | Clinica Las Vegas
Honoraria/Speaking/Consulting: Bayer Healthcare Pharmaceuticals, Pfizer, Inc, AstraZeneca, Boston Scientific, Medtronic
Aanand Ganesan, MBBS, CEPS-A | Flinders University
No relevant financial relationships with ineligible companies to disclose.
Taya Glotzer, MD, FHRS | Electrophysiology Associates
Honoraria/Speaking/Consulting: Abbott, Medtronic
Michael Gold, MD, PhD, FHRS | MUSC
Honoraria/Speaking/Consulting: CVRx, Medtronic, Boston Scientific
Bengt Herweg, MD, FHRS | University of South Florida Morsani College of Medicine
Honoraria/Speaking/Consulting: Abbott, Medtronic
Weijian Huang, MD, FHRS | First Hospital Affiliated to WZMU
No relevant financial relationships with ineligible companies to disclose.
Marek Jastrzebski, MD | SP ZOZ Szpital Uniwersytecki
No relevant financial relationships with ineligible companies to disclose
Juhani Junttila, MD, PhD | University of Oulu
Honoraria/Speaking/Consulting: Boehringer Ingelheim, BMS/Pfizer Alliance
Advisory Board Membership: Boehringer Ingelheim, BMS/Pfizer Alliance, Bayer Healthcare Pharmaceuticals
Valentina Kutyifa, MD, PhD, FHRS, FACC, FESC | University of Rochester Medical Center
Honoraria/Speaking/Consulting: Medtronic
Research (Contracted Grants for PIs and Named Investigators Only): Boston Scientific, Spire, Inc., Zoll Medical, Biotronik, Abbott
Shunmuga Sundaram Ponnusamy MBBS, MD, CEPS-A, | Velammal Medical College Hospital and Research Institute
Honoraria/Speaking/Consulting: Medtronic
John Rickard MBA, MD, MPH
Honoraria/Speaking/Consulting: St. Jude Medical, Medtronic, Boston Scientific
Research (Contracted Grants for PIs and Named Investigators Only): St. Jude
Parikshit S. Sharma, MD, MPH, FHRS | Rush University
Honoraria/Speaking/Consulting: Biotronik, Medtronic, Abbott
Pablo Morina Vazquez, MD | Hospital General Juan Ramon Jiminez
Advisory Board Membership: Abbott, Medtronic
Zachary Whinnett, BMBS | Imperial College London
Research (Contracted Grants for PIs and Named Investigators Only): Medtronic
Advisory Board Membership: Abbott, Boston Scientific, Medtronic
Francesco Zanon, MD, FHRS | Santa Maria Della Misericordia Hospital
Honoraria/Speaking/Consulting: Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort
Heart Rhythm 2023 Program Committee and Staff Disclosures can be found here.
Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
All relevant financial relationships have been mitigated.
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company within the 24 months prior to the disclosure.
The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:
Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.
Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.
Scientific Validity - those scientific studies cited in the activity conform to standards accepted by the scientific community.
Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
Omissions - that no seminal studies, data, or best evidence are missing